Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 4,879,176 | $487,917,581.00 | 5.27% |
Novo Nordisk A/S, Class B | Equity | 1,550,961 | $246,126,024.00 | 2.66% |
Microsoft Corp. | Equity | 830,771 | $239,511,279.00 | 2.59% |
ASML Holding NV | Equity | 301,638 | $206,107,730.00 | 2.23% |
Broadcom, Inc. | Equity | 313,354 | $201,029,125.00 | 2.17% |
AstraZeneca PLC | Equity | 1,330,360 | $184,654,169.00 | 1.99% |
Apple, Inc. | Equity | 1,035,135 | $170,693,762.00 | 1.84% |
Safran SA | Equity | 1,070,264 | $158,940,328.00 | 1.72% |
UnitedHealth Group, Inc. | Equity | 277,448 | $131,119,150.00 | 1.42% |
AIA Group, Ltd. | Equity | 11,657,400 | $122,488,743.00 | 1.32% |
Bristol-Myers Squibb Company | Equity | 1,559,387 | $108,081,113.00 | 1.17% |
SAP SE | Equity | 849,407 | $106,853,034.00 | 1.15% |
Alphabet, Inc., Class A | Equity | 1,018,723 | $105,672,137.00 | 1.14% |
TotalEnergies SE | Equity | 1,781,351 | $105,104,633.00 | 1.14% |
Kering SA | Equity | 154,371 | $100,751,260.00 | 1.09% |